0001231919-25-000432.txt : 20251105 0001231919-25-000432.hdr.sgml : 20251105 20251105154611 ACCESSION NUMBER: 0001231919-25-000432 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251105 DATE AS OF CHANGE: 20251105 EFFECTIVENESS DATE: 20251105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Osteal Therapeutics, Inc. CENTRAL INDEX KEY: 0001735936 ORGANIZATION NAME: EIN: 900939060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563186 FILM NUMBER: 251453639 BUSINESS ADDRESS: STREET 1: 835 LYNDON B. JOHNSON FWY STE 635 CITY: DALLAS STATE: TX ZIP: 75244 BUSINESS PHONE: (469) 809-2630 MAIL ADDRESS: STREET 1: 835 LYNDON B. JOHNSON FWY STE 635 CITY: DALLAS STATE: TX ZIP: 75244 FORMER COMPANY: FORMER CONFORMED NAME: Joint Purification Systems, Inc. DATE OF NAME CHANGE: 20180328 D 1 primary_doc.xml X0708 D LIVE 0001735936 Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 (469) 809-2630 DELAWARE Joint Purification Systems, Inc. Corporation true David Thompson c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Executive Officer Director Erik Oros c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Director Sonal Patel c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Director Martin Sands c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Director Rushu Luo c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Director Judson Cooper c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Director Biren Mehta c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Director David Cash c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Director Brian de Beaubien c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Executive Officer Director Douglas Kohrs c/o Osteal Therapeutics, Inc. 4835 LYNDON B. JOHNSON FWY STE 635 DALLAS TX TEXAS 75244 Director Pharmaceuticals Decline to Disclose 06b false 2025-10-17 false true false 0 26702156 15602151 11100005 false 10 0 0 0 false Osteal Therapeutics, Inc. /s/ David Thompson David Thompson Chief Executive Officer 2025-11-05